Basic Details
| Item | Value |
|---|---|
| Title | CatalystRadar: European Biotech Clinical-Trial and Earnings Alert App |
| Type | Web App |
| Difficulty | 55 |
| Ideal Capital | 8000 |
| ROI | 80% |
| ETA on ROI | 12 |
| Target Audience | Retail biotech investors, day/swing traders, financial analysts, and pharma professionals |
| Target Countries | Switzerland, Germany, EU, UK, USA, and global English/German-speaking markets |
| Target Demographics | Ages 25-55, male and female, finance/STEM background, interests in stock trading, clinical trials, and biotech news; desktop and mobile users |
| Description | Build a web app that aggregates and alerts on European biotech catalysts: Phase-1/2/3 data readouts, earnings releases, guidance changes, FDA/EMA filings, and insider trading. Data sources: finanznachrichten.de, company investor-relations pages, clinicaltrials.gov, EMA/CHMP announcements, and press releases. Features: a searchable catalyst calendar, push/email alerts, a watchlist, and simple valuation/sentiment scores. Tech stack: Next.js frontend, PostgreSQL database, Python scrapers with cron jobs, Stripe for payments, deployed on Vercel/AWS. Launch with a focused dataset covering Swiss/German biotech (Basilea, Idorsia, Molecular Partners, etc.), then expand to EU and US. Revenue from subscriptions. |
| Monetization | Freemium model: free basic alerts; Pro subscription at EUR 19/month or EUR 190/year for real-time alerts, full calendar, and export; API access for funds/newsletters at EUR 500/month. |
| Pros |
|
| Cons |
|
